Future prospects in cardiac magnetic resonance imaging

Current Cardiology Reports

Volumn 5, Issue 1, 2003, Pages 83-90

  Doyle, Mark ^a   Biederman, Robert W W ^b  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; EPLERENONE; GADOLINIUM; THALLIUM;

CARDIOVASCULAR DISEASE; CELL VIABILITY; CLINICAL TRIAL; COMPUTER PROGRAM; COMPUTER SYSTEM; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; HEART DISEASE; PATHOLOGY;

HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 1842865305     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-003-0042-z     Document Type: Review

References (49)

1. DeCherney GS: Accelerating acceptance. Physician Exec 1999, 25:32-38.
2. Wallis F, Gilbert FJ: Magnetic resonance imaging in oncology: an overview. J R Coll Surg Edinb 1999, 44:117-125.
3. Nienaber CA, Spielmann RP, von Kodolitsch Y, et al.: Diagnosis of thoracic aortic dissection. Magnetic resonance imaging versus transesophageal echocardiography. Circulation 1992, 85:434-447.
4. Hundley WG, Hamilton CA, Thomas MS, et al.: Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress. Circulation 1999, 100:1697-1702.
5. Shaw LJ, Miller DD: Defining quality health care with outcomes assessment while achieving economic value. Top Health Inf Manage 2000, 20:44-54.
6. Zerhouni EA, Parish DM, Rogers WJ, et al.: Human heart: tagging with MR imaging-a method for noninvasive assessment of myocardial motion. Radiology 1988, 169:59-63.
7. Axel L, Dougherty L: MR imaging of motion with spatial modulation of magnetization. Radiology 1989, 171:841-845.
8. Patz S, Hawkes RC: The application of steady-state free precession to the study of very slow fluid flow. Magn Reson Med 1986, 3:140-145.
9. Riederer SJ, Tasciyan T, Farzaneh F, et al.: MR fluoroscopy: technical feasibility. Magn Reson Med 1988, 8:1-15.
10. Hernandez RJ, Aisen AM, Foo TK, Beekman RH: Thoracic cardiovascular anomalies in children: evaluation with a fast gradient-recalled-echo sequence with cardiac-triggered segmented acquisition. Radiology 1993, 188:775-780.
11. Doyle M, Walsh EC, Blackwell GG, Pohost GM: Block regional interpolation scheme for k-space (BRISK): a rapid cardiac imaging technique. Magn Reson Med 1995, 33:163-170.
12. Roemer PB, Edelstein WA, Hayes CE, et al.: The NMR phased array. Magn Reson Med 1990, 16:192-225.
13. Sodickson DK, Manning WJ: Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med 1997, 38:591-603.
14. Weiger M, Pruessmann KP, Boesiger P: Cardiac real-time imaging using SENSE. SENSitivity Encoding scheme. Magn Reson Med 2000, 43:177-184.
15. Benjelloun H, Cranney GB, Kirk KA, et al.: Interstudy reproducibility of biplane cine nuclear magnetic resonance measurements of left ventricular function. Am J Cardiol 1991, 67:1413-1420.
16. de Graaf RG, Groen JP: MR angiography with pulsatile flow. Magn Reson Imaging 1992, 10:25-34.
17. Brady TJ, Goldman MR, Pykett IL, et al.: Proton nuclear magnetic resonance imaging of regionally ischemic canine hearts: effect of paramagnetic proton signal enhancement. Radiology 1982, 144:343-347.
18. Pereles FS, Kapoor V, Carr JC, et al.: Usefulness of segmented trueFISP cardiac pulse sequence in evaluation of congenital and acquired adult cardiac abnormalities. AJR Am J Roentgenol 2001, 177:1155-1160.
19. Plein S, Bloomer TN, Ridgway JP, et al.: Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. J Magn Reson Imaging 2001, 14:230-236.
20. Thiele H, Nagel E, Paetsch I, et al.: Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents. J Magn Reson Imaging 2001, 14:362-367.
21. Moore CC, McVeigh ER, Zerhouni EA: Noninvasive measurement of three-dimensional myocardial deformation with tagged magnetic resonance imaging during graded local ischemia. J Cardiovasc Magn Reson 1999, 1:207-222.
22. Sakuma H, Saeed M, Takeda K, et al.: Quantification of coronary artery volume flow rate using fast velocity-encoded cine MR imaging. AJR Am J Roentgenol 1997, 168:1363-1367.
23. Buchthal SD, den Hollander JA, Merz CN, et al.: Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2000, 342:829-835.
24. Pohost GM, Meduri A, Razmi RM, et al.: Cardiac MR spectroscopy in the new millennium. Rays 2001, 26:93-107.
25. Panting JR, Gatehouse PD, Yang GZ, et al.: Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002, 346:1934-1935.
26. Gibson CM, Cannon CP, Murphy SA, et al.: Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000, 101:125-130.
27. De Bruyne B, Pijls NH, Heyndrickx GR, et al.: Pressure-derived fractional flow reserve to assess serial epicardial stenoses: theoretical basis and animal validation. Circulation 2000, 101:1840-1847.
28. Langerak SE, Kunz P, Vliegen HW, et al.: MR flow mapping in coronary artery bypass grafts: a validation study with Doppler flow measurements. Radiology 2002, 222:127-135.
29. Hundley WG, Hillis LD, Hamilton CA, et al.: Assessment of coronary arterial restenosis with phase-contrast magnetic resonance imaging measurements of coronary flow reserve. Circulation 2000, 101:2375-2381.
30. Jerosch-Herold M, Wilke N, Stillman AE: Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Physics 1998, 25:73-84.
31. Little WC, Downes TR, Applegate RJ: The underlying coronary lesion in myocardial infarction: implications for coronary angiography. Clin Cardiol 1991, 14:868-874.
32. Fayad ZA, Fuster V. The human high-risk plaque and its detection by magnetic resonance imaging. Am J Cardiol 2001, 88:42E-45E.
33. Rivas PA, Nayak KS, Scott GC, et al.: In vivo real-time intravascular MRI. J Cardiovasc Magn Reson 2002, 4:223-232.
34. Lederman RJ, Guttman MA, Peters DC, et al.: Catheter-based endomyocardial injection with real-time magnetic resonance. Circulation 105:1282-1284.
35. Kellman P, Arai AE, McVeigh ER, Aletras AH: Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002, 47:372-383.
36. Kim RJ, Hillenbrand HB, Judd RM: Evaluation of myocardial viability by MRI. Herz 2000, 25:417-430.
37. Kramer CM, Rogers WJ Jr, Mankad S, et al.: Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 2000, 36:1835-1840.
38. Klein C, Nekolla SG, Bengel FM, et al.: Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002, 105:162-167.
39. Bottini PB, Carr AA, Prisant LM, et al.: Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 1995, 8:221-228.
40. Bellenger NG, Davies LC, Francis JM, et al.: Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000, 2:271-278.
41. Dahlof B, Devereux R, de Faire U, et al.: The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens 1997, 10:705-713.
42. Pitt B, Reichek N, Williams G, et al.: Late Breaking Clinical Trials, The 4E Study Efficacy and Safety of Eplerenone, Enalapril, and Eplerenone/Enalapril Combination Therapy for Essential Hypertension and Left Ventricular Hypertrophy. American College of Cardiology, 51st Annual Scientific Session. Atlanta, GA: March 17-20, 2002.
43. McConnell MV, Stuber M, Manning WJ: Clinical role of coronary magnetic resonance angiography in the diagnosis of anomalous coronary arteries. J Cardiovasc Magn Reson 2000, 2:217-224.
44. Kopp AF, Schroeder S, Baumbach A, et al.: Non-invasive characterisation of coronary lesion morphology and composition by multislice CT: first results in comparison with intracoronary ultrasound. Eur Radiol 2001, 11:1607-1611.
45. Kim WY, Danias PC, Stuber M, et al.: Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001, 345:1863-1869.
46. Nayak KS, Pauly JM, Yang PC, et al.: Real-time interactive coronary MRA. Magn Reson Med 2001, 46:430-435.
47. Potchen EJ: Prospects for progress in diagnostic imaging. J Intern Med 2000, 247:411-424.
48. Kanal E, Borgstede JP, Barkovich AJ, et al.: American College of Radiology White Paper on MR Safety. AJR Am J Roentgenol 2002, 178:1335-1347.
49. Vosshenrich R, Fischer U: Contrast-enhanced MR angiography of abdominal vessels: is there still a role for angiography? Eur Radiol 2002, 12:218-230.